Interstitial Lung Disease (ILD) Program
Interstitial Lung Disease (ILD) Program
The Interstitial Lung Disease Program at U-M Health leads the field in accurate diagnostic methods, active scientific research and extensive clinical trials.
Our Approach
The multidisciplinary team brings together specialists from pulmonology, rheumatology, cardiology, radiology and pathology. Interstitial Lung Disease Program patients can expect to be guided through the process of meeting the specialists with expertise in their specific disorder, with appointments completed in as short a time as one day. All physicians from the program meet on a bi-weekly basis to discuss each patient case related to interstitial lung disease, beginning by addressing diagnosis.
The Interstitial Lung Disease Program team ensures accurate diagnosis by bringing specialists into close collaboration from the earliest stages of patient care. The University of Michigan has tracked and tested their diagnostic methods, publishing results that set a standard of multidisciplinary approach for interstitial lung disease diagnosis nationwide. Physicians from the program are also members of an international task force that are rewriting guidelines for the diagnosis and treatment of interstitial pulmonary fibrosis.
The path that interstitial lung disease takes can be extremely variable, and treatments are still being developed to make the greatest impact in patients’ lives. The University of Michigan participates in one of the largest numbers of clinical trials related to ILD in the nation. Regular meetings of the Interstitial Lung Disease Program physicians allows for the rapid adjustments that can be necessary in patient care. Whenever possible, the program actively coordinates with a patient’s home-based physician to carry out therapies. Should it become necessary, the University of Michigan has a strong and successful lung transplant program that will allow for seamless movement to the next step in therapy.
In addition to clinical trials and improved diagnostic methods, the Interstitial Lung Disease Program is committed to finding new therapy options for patients through scientific research. Basic cellular research related to the pathobiology of interstitial lung disease has been successfully translated to a clinical study based at the University of Michigan. Research and clinical progress is actively translated across disciplines with a common goal of bettering the understanding, diagnosis and treatment for interstitial lung disease.
Services
Among the types of disorders treated by the Interstitial Lung Disease Program are:
- Ideopathic pulmonary fibrosis
- Sarcoidosis
- Non-specific Interstitial Pneumonia (NSIP)
- Scarring disease of the lung associated with autoimmune diseases such as lupus, scleroderma, myositis, rheumatoid arthritis and mixed connective tissue disease
- Respiratory bronchiolitis
- Pulmonary alveolar proteinosis
- Granulomatosis with polyangiitis
- Hypersensitivity pneumonitis
- Rheumatoid lung
- Evaluation for lung transplant
Appointment Information
To make an appointment related to a lung or pulmonary problem, or for an interstitial lung disease referral, call us at 888-287-1084.
Locations
-
Pulmonary Clinic | Taubman Center 1500 E Medical Center Dr
Floor 3 Reception C
Ann Arbor, MI 48109-5361Get Directions
Doctors
Elizabeth Anne Belloli, MD
Clinical Associate Professor
Pulmonary Diseases, Critical Care Medicine, Internal Medicine
Kevin Robert Flaherty, MD
Professor
Pulmonary Diseases, Critical Care Medicine, Internal Medicine
David Noel O'Dwyer, MB BCH BAO, PhD
Associate Professor
Pulmonary Diseases, Critical Care Medicine, Internal Medicine
Justin M Oldham, MD, MS
Clinical Associate Professor
Pulmonary Diseases, Critical Care Medicine
Janelle Vu Pugashetti, MD, MS
Assistant Professor
Pulmonary Diseases, Internal Medicine
Jamie Sue Votava Sheth, MD
Clinical Assistant Professor
Pulmonary Diseases, Critical Care Medicine, Internal Medicine
Bonnie Ren Shiaw Wang, MD
Clinical Associate Professor
Pulmonary Diseases, Internal Medicine, Critical Care Medicine
News & Stories
A gene discovery that changed cystic fibrosis care, and genetic research, forever
The most effective prevention method for complications post lung transplant
Bacteria in the mouth linked to pulmonary fibrosis survival
A rare diagnosis and a young mother who’s spreading the word